Spero director granted RSUs and stock options
Spero Therapeutics director Patrick V.J.J.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Spero Therapeutics director Patrick V.J.J. Vink received new equity awards. He was granted 10,000 restricted stock units, each representing one future common share upon vesting on June 23, 2027, subject to continued service. He was also awarded options on 20,000 shares at an exercise price of $2.15 per share, vesting in full on June 23, 2027 and expiring on June 23, 2036. Following these grants, he directly owns 85,000 common shares.
Insider Trade Summary
Grant/Award: 30,000 shares
Grant/Award
2 txns
Insider
VINK PATRICK V.J.J.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 20,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 10,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 20,000 contracts (Direct);
Common Stock — 85,000 shares (Direct)
Footnotes (2)
- F1. Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on June 23, 2027, subject to the Reporting Person's continued service through the applicable vesting date.
- F2. The shares underlying this option will vest and become exercisable in full on June 23, 2027 subject to the Reporting Person's continued service as a director through the vesting date.
Key Figures
RSU grant: 10,000 RSUs
Option grant size: 20,000 options
Option exercise price: $2.15 per share
+4 more
7 metrics
RSU grant
10,000 RSUs
Granted June 23, 2026; each RSU equals one common share at vesting
Option grant size
20,000 options
Stock Option (right to buy) granted June 23, 2026
Option exercise price
$2.15 per share
Conversion/exercise price for 20,000 stock options
Option expiration
June 23, 2036
Expiration date of the 20,000-share stock option grant
Equity holdings after grant
85,000 shares
Total common shares directly owned after RSU grant
RSU vesting date
June 23, 2027
RSUs vest in full on this date, subject to continued service
Option vesting date
June 23, 2027
Options become fully exercisable on this date
Key Terms
restricted stock units ("RSUs"), Stock Option (right to buy), vesting, exercise price
4 terms
restricted stock units ("RSUs") financial
"Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (right to buy) financial
"Stock Option (right to buy) with an exercise price of 2.1500 per share"
vesting financial
"The RSUs vest on June 23, 2027, subject to the Reporting Person's continued service"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price: "2.1500" for the stock option grant"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Spero Therapeutics (SPRO) disclose for Patrick V.J.J. Vink?
Spero Therapeutics reported that director Patrick V.J.J. Vink received 10,000 restricted stock units and stock options for 20,000 shares on June 23, 2026. Both awards were granted at no cash cost as part of his equity compensation.
What are the key terms of Patrick V.J.J. Vink’s new stock options at Spero Therapeutics (SPRO)?
Vink received options covering 20,000 Spero Therapeutics shares at an exercise price of $2.15 per share. These options vest and become fully exercisable on June 23, 2027, contingent on his continued service as a director, and expire on June 23, 2036.
When do Patrick V.J.J. Vink’s Spero Therapeutics restricted stock units vest?
The 10,000 restricted stock units granted to Patrick V.J.J. Vink vest on June 23, 2027. Each RSU converts into one share of Spero Therapeutics common stock at that time, assuming he continues serving through the vesting date as specified.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates